Newest Businesses in Missouri

Browse newly-funded private companies headquartered in Missouri. Sorted by filing date, with the most recent on top.

About Missouri

Missouri's Form D filings cluster in St. Louis (biotech via Washington University, defense, agriculture), Kansas City (animal-health, fintech, SaaS), and occasional filings from Springfield. St. Louis's Washington University research ecosystem drives biotech and medtech filings. Kansas City hosts the Animal Health Corridor (crossing into Kansas), fintech (H&R Block, financial-services companies), and SaaS. Round sizes typically range $5M–$40M with occasional larger biotech filings. Delaware incorporation dominates; Missouri LLCs appear for real-estate vehicles.

In 2026, Missouri accounts for 22 catalogued filings totaling $6415.4M, running at roughly 4.9 filings per week over the last 30 days.

Total raised
$6415.4M
Median offering
$10M
Active cities
9
Last 30 days
21

Top cities

Featured Missouri companies in 2026

About private capital in Missouri

Missouri has moderate corporate tax rates and a regulatory environment shaped by the state's agricultural, animal-health, and manufacturing economies. St. Louis's Washington University research infrastructure drives biotech and life-science filing activity. Kansas City's Animal Health Corridor produces distinctive veterinary-medicine filings. The state's logistics position (I-70 and I-44 crossroads) supports logistics-tech filings. Real-estate vehicles target Missouri commercial and multifamily property. Operating companies incorporate in Delaware.

Missouri funding trends

Recent Missouri Form D filings show several patterns. First, St. Louis biotech and medtech companies file regularly from Washington University spinouts. Second, Kansas City animal-health and veterinary-medicine filings contribute distinctive volume. Third, fintech filings tie to the region's financial-services anchors. Fourth, logistics-tech filings reflect Missouri's crossroads geography. Fifth, real-estate vehicles target Missouri commercial and multifamily property. Missouri's filing volume is moderate, with distinctive biotech and animal-health sub-categories.